European agency recommends two new adalimumab biosimilarsSeptember 20, 2021Rheumatoid ArthritisSpondyloarthropathiesPsoriatic ArthritisPediatricsAnkylosing spondylitis
Low RA flare rate reported after Pfizer COVID vaccinationSeptember 15, 2021Rheumatoid ArthritisCOVID-19 Updates
Three JAK inhibitors get boxed warnings, modified indicationsSeptember 2, 2021Rheumatoid ArthritisPsoriatic ArthritisPediatrics
NIH to study COVID vaccine booster in people with autoimmune diseaseAugust 27, 2021COVID-19 UpdatesRheumatoid ArthritisLupus & Connective Tissue Diseases
In RA patients, multiple comorbidities lower odds of disease controlAugust 23, 2021Rheumatoid Arthritis
New options explored for sarcopenia in rheumatic diseasesAugust 19, 2021Lupus & Connective Tissue DiseasesRheumatoid Arthritis
Tocilizumab shortage continues as pandemic wears onAugust 19, 2021Rheumatoid ArthritisLupus & Connective Tissue DiseasesCOVID-19 UpdatesPediatrics
HBV screening often incomplete or forgone when starting tocilizumab, tofacitinibAugust 9, 2021Rheumatoid ArthritisPediatricsPsoriatic ArthritisLupus & Connective Tissue Diseases
COVID-19 vaccine hesitancy still weighs heavy for some rheumatic disease patientsJuly 21, 2021COVID-19 UpdatesRheumatoid ArthritisSpondyloarthropathiesPsoriatic ArthritisAnkylosing spondylitisLupus & Connective Tissue Diseases
Vertebral fractures still a risk with low-dose oral glucocorticoids for RAJuly 20, 2021Rheumatoid ArthritisOsteoporosis
Novel study links air pollution to increased risk of rheumatoid arthritis flaresJune 8, 2021Rheumatoid Arthritis
Patients with RA on rituximab at risk for worse COVID-19 outcomesJune 8, 2021Rheumatoid ArthritisCOVID-19 Updates
Secondhand smoke in childhood and adulthood linked to increased risk of rheumatoid arthritisJune 5, 2021Rheumatoid Arthritis
